Granger, C. B., Diener, H.-C., Sacco, R., Easton, J., Cronin, L., Fräßdorf, M., … Brueckmann, M. (2019). MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL). In Journal of the American College of Cardiology (Vol. 73, pp. 1757–1757). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)32363-0

Granger, Christopher B., Hans-Christoph Diener, Ralph Sacco, J. Easton, Lisa Cronin, Mandy Fräßdorf, Claudia Grauer, and Martina Brueckmann. “MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL).” In Journal of the American College of Cardiology, 73:1757–1757. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)32363-0.

Granger CB, Diener H-C, Sacco R, Easton J, Cronin L, Fräßdorf M, et al. MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL). In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 1757–1757.

Granger, Christopher B., et al. “MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL).” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 1757–1757. Crossref, doi:10.1016/s0735-1097(19)32363-0.

Granger CB, Diener H-C, Sacco R, Easton J, Cronin L, Fräßdorf M, Grauer C, Brueckmann M. MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL). Journal of the American College of Cardiology. Elsevier BV; 2019. p. 1757–1757.